Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Wilmington Pharmaceuticals

Wilmington Pharmaceuticals
2002 FOUNDED
PRIVATE STATUS
PE Growth LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Developer of patient-friendly, fast-dissolving formulations for established medicines. The company specializes in the fast-dissolving drug delivery method and applies to commercial medicines.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Delivery
Primary Office
  • 1904 Eastwood Road
  • Suite 305
  • Wilmington, NC 28403
  • United States

+1 (910) 000-0000

Wilmington Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Wilmington Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Wilmington Pharmaceuticals Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Wilmington Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Wilmington Pharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
Eugene Haley Founder and Chief Executive Officer
Thomas Aluise Chief Financial Officer